First Patient Begins Therapy with MABp1 for Treatment of Atopic Dermatitis XBiotech Inc. (NASDAQ:XBIT) announced today that the first patient has been enrolled in its …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
